Publicacións en colaboración con investigadores/as de Pharmacoeconomics and Outcomes Research Iberia (1)

2017

  1. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: Update based on the clinical evidence in Spain

    BMC Infectious Diseases, Vol. 17, Núm. 1